BCL2L2 Antikörper
Kurzübersicht für BCL2L2 Antikörper (ABIN6936493)
Target
Alle BCL2L2 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Spezifität
- BCLW promotes cell survival. Blocks dexamethasone-induced apoptosis. Mediates survival of postmitotic Sertoli cells by suppressing death-promoting activity of BAX.
-
Kreuzreaktivität (Details)
- Human.
-
Aufreinigung
- 1.0mg/ml of Ab purified from Bioreactor by Protein A/G.
-
Immunogen
- Recombinant human full-length BCL2L2 protein
-
Isotyp
- IgG1 kappa
-
-
-
-
Applikationshinweise
-
Known_Application: ELISA (For coating, order antibody without BSA), ,Western Blot (1-2 μg/mL), ,Optimal dilution for a specific application should be determined.
Positive_Control: PC-3, HEK293, HePG2, MCF-7 or U87 cells.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Konzentration
- 1.0 mg/mL
-
Buffer
- Prepared in 10 mM PBS, WITHOUT BSA and Azide.
-
Konservierungsmittel
- Azide free
-
Lagerung
- -20 °C,-80 °C
-
Informationen zur Lagerung
- Antibody without azide store at -20 to -80 °C. Antibody is stable for 24 months. Non-hazardous.
-
Haltbarkeit
- 24 months
-
-
- BCL2L2 (BCL2-Like 2 (BCL2L2))
-
Andere Bezeichnung
- BCL2L2
-
Hintergrund
-
BCL-W, BCL2-L-2, BCLW, KIAA0271, PPP1R51,BCL2-like 2
Cellular localisation: Ubiquitous cytoplasmic expression. -
Molekulargewicht
- 22-30kDa
-
Gen-ID
- 599, 410026
-
UniProt
- Q92843
Target
-